{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:07:10Z","timestamp":1788905230913,"version":"build-2803163510"},"reference-count":243,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA270783-01"],"award-info":[{"award-number":["1R01CA270783-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1R01EY033423-01A1"],"award-info":[{"award-number":["1R01EY033423-01A1"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL146736-01"],"award-info":[{"award-number":["R01HL146736-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.addr.2024.115305","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T09:34:25Z","timestamp":1713260065000},"page":"115305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines"],"prefix":"10.1016","volume":"209","author":[{"given":"Namratha","family":"Turuvekere Vittala Murthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kseniia","family":"Vlasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Jozic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-0500","authenticated-orcid":false,"given":"Gaurav","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.addr.2024.115305_b0005","doi-asserted-by":"crossref","first-page":"Article 12","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nature Nanotechnology"},{"issue":"7","key":"10.1016\/j.addr.2024.115305_b0010","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Molecular Therapy"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b0015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jgm.696","article-title":"Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis","volume":"7","author":"Akinc","year":"2005","journal-title":"The Journal of Gene Medicine"},{"issue":"7966","key":"10.1016\/j.addr.2024.115305_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-023-06133-1","article-title":"Engineered tRNAs suppress nonsense mutations in cells and in vivo","volume":"618","author":"Albers","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115305_b0025","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jcf.2022.12.016","article-title":"Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis","volume":"22","author":"Allaire","year":"2023","journal-title":"Journal of Cystic Fibrosis"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2217\/nnm.14.192","article-title":"Combinatorial library strategies for synthesis of cationic lipid-like nanoparticles and their potential medical applications","volume":"10","author":"Alt\u0131noglu","year":"2015","journal-title":"Nanomedicine (london, England)"},{"issue":"9157","key":"10.1016\/j.addr.2024.115305_b0035","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(98)06532-5","article-title":"Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial","volume":"353","author":"Alton","year":"1999","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.addr.2024.115305_b0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-2600(15)00245-3","article-title":"Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: A randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"Alton, E. W. F. W., Armstrong, D. K., Ashby, D., Bayfield, K. J., Bilton, D., Bloomfield, E. V., Boyd, A. C., Brand, J., Buchan, R., Calcedo, R., Carvelli, P., Chan, M., Cheng, S. H., Collie, D. D. S., Cunningham, S., Davidson, H. E., Davies, G., Davies, J. C., Davies, L. A., UK Cystic Fibrosis Gene Therapy Consortium","year":"2015","journal-title":"The Lancet. Respiratory Medicine"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/thoraxjnl-2016-208406","article-title":"Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis","volume":"72","author":"Alton","year":"2017","journal-title":"Thorax"},{"issue":"17\u201318","key":"10.1016\/j.addr.2024.115305_b0050","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/hum.2020.142","article-title":"Gene Therapy for Respiratory Diseases: Progress and a Changing Context","volume":"31","author":"Alton","year":"2020","journal-title":"Human Gene Therapy"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ng1093-135","article-title":"Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice","volume":"5","author":"Alton","year":"1993","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D1BM01454D","article-title":"Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)","volume":"10","author":"\u00c1lvarez-Benedicto","year":"2022","journal-title":"Biomaterials Science"},{"key":"10.1016\/j.addr.2024.115305_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2023.03.004","article-title":"Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor","author":"Amistadi","year":"2023","journal-title":"Molecular Therapy"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s41061-017-0128-5","article-title":"Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment","volume":"375","author":"Amreddy","year":"2017","journal-title":"Topics in Current Chemistry (cham)"},{"issue":"7785","key":"10.1016\/j.addr.2024.115305_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115305_b0080","unstructured":"Arcturus\u2019 Pipeline of mRNA Medicines and Vaccines for Rare Diseases Cystic Fibrosis (CF), Covid-19, Influenza (Flu), Ornithine Transcarbamylase Deficiency (OTCD). (n.d.). Retrieved November 6, 2023, from https:\/\/arcturusrx.com\/mrna-medicines-pipeline\/#pipelineGroup_lunarCf."},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5152\/ejp.2014.00087","article-title":"Jet, Ultrasonic, and Mesh Nebulizers: An Evaluation of Nebulizers for Better Clinical Outcomes","volume":"16","author":"Ari","year":"2014","journal-title":"Eurasian Journal of Pulmonology"},{"key":"10.1016\/j.addr.2024.115305_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00074","article-title":"Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis","volume":"10","author":"Berical","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.addr.2024.115305_b0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biocel.2014.02.009","article-title":"Effects of airway surface liquid pH on host defense in cystic fibrosis","volume":"52","author":"Berkebile","year":"2014","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2011.09.098","article-title":"The journey of a drug-carrier in the body: An anatomo-physiological perspective","volume":"161","author":"Bertrand","year":"2012","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"16","key":"10.1016\/j.addr.2024.115305_b0105","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/j.addr.2024.115305_b0110","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/sj.gt.3301039","article-title":"Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs","volume":"6","author":"Bragonzi","year":"1999","journal-title":"Gene Therapy"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2008.05.016","article-title":"Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: Disulfide bonds boost intracellular release of the cargo","volume":"130","author":"Breunig","year":"2008","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"36","key":"10.1016\/j.addr.2024.115305_b0120","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1073\/pnas.0703882104","article-title":"Breaking up the correlation between efficacy and toxicity for nonviral gene delivery","volume":"104","author":"Breunig","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1165\/rcmb.2008-0170OC","article-title":"Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-\/- mice","volume":"40","author":"Bruscia","year":"2009","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.addr.2024.115305_b0130","doi-asserted-by":"crossref","unstructured":"Bruscia, E. M., Zhang, P.-X., Satoh, A., Caputo, C., Medzhitov, R., Shenoy, A., Egan, M. E., & Krause, D. S. (2011). Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis. Journal of Immunology (Baltimore, Md.: 1950), 186(12), 6990\u20136998. doi: 10.4049\/jimmunol.1100396.","DOI":"10.4049\/jimmunol.1100396"},{"issue":"6097","key":"10.1016\/j.addr.2024.115305_b0135","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.1223012","article-title":"A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia","volume":"337","author":"Button","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.addr.2024.115305_b0140","first-page":"11","article-title":"Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis","author":"Cabrini","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b0145","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jphp.12541","article-title":"The function and performance of aqueous aerosol devices for inhalation therapy","volume":"68","author":"Carvalho","year":"2016","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"31","key":"10.1016\/j.addr.2024.115305_b0150","first-page":"e2303370","article-title":"Induction of Bleb Structures in Lipid Nanoparticle Formulations of mRNA Leads to Improved Transfection Potency. Advanced Materials (Deerfield Beach","volume":"35","author":"Cheng","year":"2023","journal-title":"Fla.)"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nature Nanotechnology"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0160","doi-asserted-by":"crossref","DOI":"10.1038\/ng0293-151","article-title":"Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA","volume":"3","author":"Chu","year":"1993","journal-title":"Nature Genetics"},{"key":"10.1016\/j.addr.2024.115305_b0165","doi-asserted-by":"crossref","unstructured":"Cooney, A. L., Abou Alaiwa, M. H., Shah, V. S., Bouzek, D. C., Stroik, M. R., Powers, L. S., Gansemer, N. D., Meyerholz, D. K., Welsh, M. J., Stoltz, D. A., Sinn, P. L., & McCray, P. B. (n.d.). Lentiviral-mediated phenotypic correction of cystic fibrosis pigs. JCI Insight, 1(14), e88730. doi: 10.1172\/jci.insight.88730.","DOI":"10.1172\/jci.insight.88730"},{"issue":"11","key":"10.1016\/j.addr.2024.115305_b0170","first-page":"538","article-title":"Cystic Fibrosis Gene Therapy: Looking Back","volume":"9","author":"Cooney","year":"2018","journal-title":"Looking Forward. Genes"},{"issue":"24","key":"10.1016\/j.addr.2024.115305_b0175","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1111\/febs.15731","article-title":"The role of goblet cells in viral pathogenesis","volume":"288","author":"Cortez","year":"2021","journal-title":"The Febs Journal"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0180","first-page":"L997","article-title":"Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. American Journal of Physiology. Lung Cellular and Molecular","volume":"284","author":"Corvol","year":"2003","journal-title":"Physiology"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1021\/bm049577p","article-title":"PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: New carriers for gene delivery","volume":"6","author":"Csaba","year":"2005","journal-title":"Biomacromolecules"},{"issue":"7","key":"10.1016\/j.addr.2024.115305_b0190","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.addr.2024.115305_b0195","unstructured":"Cystic Fibrosis\u2014Symptoms | NHLBI, NIH. (2022, March 24). https:\/\/www.nhlbi.nih.gov\/health\/cystic-fibrosis\/symptoms."},{"issue":"17\u201318","key":"10.1016\/j.addr.2024.115305_b0200","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1089\/hum.2020.137","article-title":"Treating Cystic Fibrosis with mRNA and CRISPR","volume":"31","author":"Da Silva Sanchez","year":"2020","journal-title":"Human Gene Therapy"},{"issue":"8","key":"10.1016\/j.addr.2024.115305_b0205","doi-asserted-by":"crossref","DOI":"10.1038\/nnano.2014.84","article-title":"In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight","volume":"9","author":"Dahlman","year":"2014","journal-title":"Nature Nanotechnology"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41385-020-00370-7","article-title":"Cellular and functional heterogeneity of the airway epithelium","volume":"14","author":"Davis","year":"2021","journal-title":"Mucosal Immunology"},{"issue":"50","key":"10.1016\/j.addr.2024.115305_b0215","doi-asserted-by":"crossref","first-page":"50393","DOI":"10.1074\/jbc.M309026200","article-title":"Enhanced Viscoelasticity of Human Cystic Fibrotic Sputum Correlates with Increasing Microheterogeneity in Particle Transport*","volume":"278","author":"Dawson","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"7491","key":"10.1016\/j.addr.2024.115305_b0220","doi-asserted-by":"crossref","DOI":"10.1038\/nature12930","article-title":"Alveolar progenitor and stem cells in lung development, renewal and cancer","volume":"507","author":"Desai","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.addr.2024.115305_b0225","doi-asserted-by":"crossref","DOI":"10.1038\/ncb1456","article-title":"CFTR regulates phagosome acidification in macrophages and alters bactericidal activity","volume":"8","author":"Di","year":"2006","journal-title":"Nature Cell Biology"},{"issue":"52","key":"10.1016\/j.addr.2024.115305_b0230","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.addr.2024.115305_b0235","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2023.07.058","article-title":"The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles","volume":"361","author":"Dilliard","year":"2023","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jcf.2019.05.014","article-title":"Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis","volume":"19","author":"Drevinek","year":"2020","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0245","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1165\/ajrcmb.18.6.2987","article-title":"Lef1 Transcription Factor Expression Defines Airway Progenitor Cell Targets for In Utero Gene Therapy of Submucosal Gland in Cystic Fibrosis","volume":"18","author":"Duan","year":"1998","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0250","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/hum.1997.8.4-431","article-title":"Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro","volume":"8","author":"Duncan","year":"1997","journal-title":"Human Gene Therapy"},{"issue":"10059","key":"10.1016\/j.addr.2024.115305_b0255","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"The Lancet"},{"issue":"8","key":"10.1016\/j.addr.2024.115305_b0260","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1039\/D1MH00185J","article-title":"Engineered \u03b5-decalactone lipomers bypass the liver to selectively in vivo deliver mRNA to the lungs without targeting ligands","volume":"8","author":"Elwakil","year":"2021","journal-title":"Materials Horizons"},{"issue":"138","key":"10.1016\/j.addr.2024.115305_b0265","doi-asserted-by":"crossref","first-page":"138ra79","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.addr.2024.115305_b0270","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.omtm.2020.05.002","article-title":"Allele-Specific Prevention of Nonsense-Mediated Decay in Cystic Fibrosis Using Homology-Independent Genome Editing","volume":"17","author":"Erwood","year":"2020","journal-title":"Molecular Therapy. Methods & Clinical Development"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0005-2736(92)90316-E","article-title":"Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity","volume":"1111","author":"Farhood","year":"1992","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0280","doi-asserted-by":"crossref","first-page":"L1123","DOI":"10.1152\/ajplung.00049.2005","article-title":"Gene transfer of CFTR to airway epithelia: Low levels of expression are sufficient to correct Cl\u2212 transport and overexpression can generate basolateral CFTR","volume":"289","author":"Farmen","year":"2005","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"7","key":"10.1016\/j.addr.2024.115305_b0285","doi-asserted-by":"crossref","DOI":"10.1038\/sj.gt.3300459","article-title":"Effect of co-lipids in enhancing cationic lipid-mediated gene transfer in vitro and in vivo","volume":"4","author":"Fasbender","year":"1997","journal-title":"Gene Therapy"},{"issue":"11","key":"10.1016\/j.addr.2024.115305_b0290","doi-asserted-by":"crossref","DOI":"10.1038\/sj.gt.3300524","article-title":"A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia","volume":"4","author":"Fasbender","year":"1997","journal-title":"Gene Therapy"},{"issue":"21","key":"10.1016\/j.addr.2024.115305_b0295","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure","volume":"84","author":"Felgner","year":"1987","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6307","key":"10.1016\/j.addr.2024.115305_b0300","doi-asserted-by":"crossref","DOI":"10.1038\/349351a0","article-title":"Gene therapeutics","volume":"349","author":"Felgner","year":"1991","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.addr.2024.115305_b0305","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0169-409X(02)00145-X","article-title":"Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis","volume":"54","author":"Ferrari","year":"2002","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"18","key":"10.1016\/j.addr.2024.115305_b0310","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/sj.gt.3301525","article-title":"Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium","volume":"8","author":"Ferrari","year":"2001","journal-title":"Gene Therapy"},{"issue":"10","key":"10.1016\/j.addr.2024.115305_b0315","doi-asserted-by":"crossref","DOI":"10.1038\/sj.gt.3300503","article-title":"ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo","volume":"4","author":"Ferrari","year":"1997","journal-title":"Gene Therapy"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0320","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0167-4781(99)00153-0","article-title":"Polyethylenimine shows properties of interest for cystic fibrosis gene therapy","volume":"1447","author":"Ferrari","year":"1999","journal-title":"Biochimica Et Biophysica Acta (BBA) - Gene Structure and Expression"},{"issue":"8","key":"10.1016\/j.addr.2024.115305_b0325","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1023\/A:1014861900478","article-title":"A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity","volume":"16","author":"Fischer","year":"1999","journal-title":"Pharmaceutical Research"},{"issue":"51","key":"10.1016\/j.addr.2024.115305_b0330","doi-asserted-by":"crossref","first-page":"36193","DOI":"10.1074\/jbc.274.51.36193","article-title":"Correction of Aberrant Splicing of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene by Antisense Oligonucleotides *","volume":"274","author":"Friedman","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0335","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-291X(91)91366-K","article-title":"A novel cationic liposome reagent for efficient transfection of mammalian cells","volume":"179","author":"Gao","year":"1991","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"10","key":"10.1016\/j.addr.2024.115305_b0340","first-page":"710","article-title":"Cationic liposome-mediated gene transfer","volume":"2","author":"Gao","year":"1995","journal-title":"Gene Therapy"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0345","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.stem.2020.01.019","article-title":"CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank","volume":"26","author":"Geurts","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.addr.2024.115305_b0350","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000940","article-title":"Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids","volume":"4","author":"Geurts","year":"2021","journal-title":"Life Science Alliance"},{"key":"10.1016\/j.addr.2024.115305_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122491","article-title":"Gene transfection using branched cationic amphiphilic compounds for an aerosol administration in cystic fibrosis context","volume":"631","author":"Ghanem","year":"2023","journal-title":"International Journal of Pharmaceutics"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0360","doi-asserted-by":"crossref","DOI":"10.1038\/ng0295-126","article-title":"Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect","volume":"9","author":"Goldman","year":"1995","journal-title":"Nature Genetics"},{"issue":"9","key":"10.1016\/j.addr.2024.115305_b0365","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.gt.3300473","article-title":"Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC","volume":"4","author":"Gorman","year":"1997","journal-title":"Gene Therapy"},{"issue":"9","key":"10.1016\/j.addr.2024.115305_b0370","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/acsinfecdis.9b00084","article-title":"Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines","volume":"5","author":"Goswami","year":"2019","journal-title":"ACS Infectious Diseases"},{"issue":"9","key":"10.1016\/j.addr.2024.115305_b0375","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.gt.3300717","article-title":"Polyethylenimine-based intravenous delivery of transgenes to mouse lung","volume":"5","author":"Goula","year":"1998","journal-title":"Gene Therapy"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0380","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/ar7002336","article-title":"A combinatorial polymer library approach yields insight into nonviral gene delivery","volume":"41","author":"Green","year":"2008","journal-title":"Accounts of Chemical Research"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0385","doi-asserted-by":"crossref","DOI":"10.1038\/sj.gt.3300562","article-title":"Comparison between intratracheal and intravenous administration of liposome\u2013DNA complexes for cystic fibrosis lung gene therapy","volume":"5","author":"Griesenbach","year":"1998","journal-title":"Gene Therapy"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0390","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/biomedicines10010107","article-title":"Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through","volume":"10","author":"Gurumoorthy","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0395","article-title":"An ionizable lipid toolbox for RNA delivery. Nature","volume":"12","author":"Han","year":"2021","journal-title":"Communications"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0400","doi-asserted-by":"crossref","first-page":"Article 1","DOI":"10.1038\/s41598-018-34960-0","article-title":"Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis","volume":"8","author":"Haque","year":"2018","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b0405","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcf.2012.07.003","article-title":"Innate immunity in cystic fibrosis lung disease","volume":"11","author":"Hartl","year":"2012","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0410","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00005-011-0113-6","article-title":"The cystic fibrosis neutrophil: A specialized yet potentially defective cell","volume":"59","author":"Hayes","year":"2011","journal-title":"Archivum Immunologiae Et Therapiae Experimentalis"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0415","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prrv.2007.02.009","article-title":"Mucolytics in cystic fibrosis","volume":"8","author":"Henke","year":"2007","journal-title":"Paediatric Respiratory Reviews"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0420","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1513\/pats.200409-046TA","article-title":"Deposition of Inhaled Particles in the Human Respiratory Tract and Consequences for Regional Targeting in Respiratory Drug Delivery","volume":"1","author":"Heyder","year":"2004","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1016\/j.addr.2024.115305_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121876","article-title":"In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications","volume":"291","author":"Huang","year":"2022","journal-title":"Biomaterials"},{"issue":"6417","key":"10.1016\/j.addr.2024.115305_b0430","doi-asserted-by":"crossref","DOI":"10.1038\/362250a0","article-title":"Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy","volume":"362","author":"Hyde","year":"1993","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b0435","doi-asserted-by":"crossref","first-page":"Article 5","DOI":"10.1038\/nbt1399","article-title":"CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression","volume":"26","author":"Hyde","year":"2008","journal-title":"Nature Biotechnology"},{"issue":"13","key":"10.1016\/j.addr.2024.115305_b0440","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/sj.gt.3301212","article-title":"Repeat administration of DNA\/liposomes to the nasal epithelium of patients with cystic fibrosis","volume":"7","author":"Hyde","year":"2000","journal-title":"Gene Therapy"},{"key":"10.1016\/j.addr.2024.115305_b0445","unstructured":"Ionis Pharmaceuticals, Inc. (2021). A Double-Blind, Placebo-Controlled, Dose-Escalation, Phase 1\/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ION-827359, an Antisense Oligonucleotide Inhibitor of ENaC, Administered to Healthy Volunteers and Patients With Cystic Fibrosis (Clinical Trial Registration NCT03647228). clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT03647228."},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0450","first-page":"690","article-title":"Novel therapeutic approaches for the management of cystic fibrosis","volume":"15","author":"Jaques","year":"2020","journal-title":"Multidisciplinary Respiratory Medicine"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0455","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2009.10.010","article-title":"Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation","volume":"142","author":"Jensen","year":"2010","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"5132","key":"10.1016\/j.addr.2024.115305_b0460","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1126\/science.8211164","article-title":"Altered Fluid Transport Across Airway Epithelium in Cystic Fibrosis","volume":"262","author":"Jiang","year":"1993","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.addr.2024.115305_b0465","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1089\/hum.1998.9.11-1531","article-title":"Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo","volume":"9","author":"Jiang","year":"1998","journal-title":"Human Gene Therapy"},{"issue":"6096","key":"10.1016\/j.addr.2024.115305_b0470","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A Programmable Dual-RNA\u2013Guided DNA Endonuclease in Adaptive Bacterial Immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0992-21","article-title":"Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis","volume":"2","author":"Johnson","year":"1992","journal-title":"Nature Genetics"},{"key":"10.1016\/j.addr.2024.115305_b0480","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.omtn.2023.06.020","article-title":"Protospacer modification improves base editing of a canonical splice site variant and recovery of CFTR function in human airway epithelial cells","volume":"33","author":"Joynt","year":"2023","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"10","key":"10.1016\/j.addr.2024.115305_b0485","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1021\/acs.nanolett.8b02917","article-title":"Optimization of a Degradable Polymer-Lipid Nanoparticle for Potent Systemic Delivery of mRNA to the Lung Endothelium and Immune Cells","volume":"18","author":"Kaczmarek","year":"2018","journal-title":"Nano Letters"},{"issue":"44","key":"10.1016\/j.addr.2024.115305_b0490","doi-asserted-by":"crossref","first-page":"13808","DOI":"10.1002\/anie.201608450","article-title":"Polymer-Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs","volume":"55","author":"Kaczmarek","year":"2016","journal-title":"Angewandte Chemie (international Ed. in English)"},{"key":"10.1016\/j.addr.2024.115305_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120966","article-title":"Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles","volume":"275","author":"Kaczmarek","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0500","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1535-7163.MCT-12-0956","article-title":"Poly(\u03b2-amino ester) nanoparticle delivery of TP53 has activity against small cell lung cancer in vitro and in vivo","volume":"12","author":"Kamat","year":"2013","journal-title":"Molecular Cancer Therapeutics"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b0505","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1021\/nl5048972","article-title":"Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature","volume":"15","author":"Khan","year":"2015","journal-title":"Nano Letters"},{"issue":"52","key":"10.1016\/j.addr.2024.115305_b0510","doi-asserted-by":"crossref","first-page":"14397","DOI":"10.1002\/anie.201408221","article-title":"Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivo","volume":"53","author":"Khan","year":"2014","journal-title":"Angewandte Chemie (international Ed. in English)"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0515","doi-asserted-by":"crossref","first-page":"1900123","DOI":"10.1002\/adtp.201900123","article-title":"A 50-nm-Sized Micellar Assembly of Thermoresponsive Polymer-Antisense Oligonucleotide Conjugates for Enhanced Gene Knockdown in Lung Cancer by Intratracheal Administration","volume":"3","author":"Kim","year":"2020","journal-title":"Advanced Therapeutics"},{"key":"10.1016\/j.addr.2024.115305_b0520","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","article-title":"Self-assembled mRNA vaccines","volume":"170","author":"Kim","year":"2021","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.addr.2024.115305_b0525","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0530","first-page":"Article 1","article-title":"Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy. Nature","volume":"13","author":"Kim","year":"2022","journal-title":"Communications"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0535","article-title":"Exon-skipping antisense oligonucleotides for cystic fibrosis therapy","volume":"119","author":"Kim","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.addr.2024.115305_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2023.03.052","article-title":"On the mechanism of tissue-selective gene delivery by lipid nanoparticles","author":"Kimura","year":"2023","journal-title":"Journal of Controlled Release"},{"issue":"17\u201318","key":"10.1016\/j.addr.2024.115305_b0545","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1089\/hum.2020.160","article-title":"Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis","volume":"31","author":"King","year":"2020","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.addr.2024.115305_b0550","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcf.2004.05.042","article-title":"Gene delivery systems\u2014Gene therapy vectors for cystic fibrosis","volume":"3","author":"Klink","year":"2004","journal-title":"Journal of Cystic Fibrosis"},{"issue":"12","key":"10.1016\/j.addr.2024.115305_b0555","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/hum.2004.15.1255","article-title":"Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution","volume":"15","author":"Konstan","year":"2004","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.addr.2024.115305_b0560","article-title":"Ionizable Amino-Polyesters Synthesized via Ring Opening Polymerization of Tertiary Amino-Alcohols for Tissue Selective mRNA Delivery. Advanced Materials (Deerfield Beach","volume":"e1801151","author":"Kowalski","year":"2018","journal-title":"Fla.)"},{"issue":"18","key":"10.1016\/j.addr.2024.115305_b0565","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1093\/nar\/gkab788","article-title":"Functional correction of CFTR mutations in human airway epithelial cells using adenine base editors","volume":"49","author":"Krishnamurthy","year":"2021","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.addr.2024.115305_b0570","article-title":"Shuttle Peptide Delivers Base Editor RNPs to Rhesus Monkey Airway Epithelial Cells In Vivo","author":"Kulhankova","year":"2023","journal-title":"Research Square"},{"key":"10.1016\/j.addr.2024.115305_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119196","article-title":"In vivo deposition study of a new generation nebuliser utilising hybrid resonant acoustic (HYDRA) technology","volume":"580","author":"Kwok","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115305_b0580","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.603039","article-title":"Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine","volume":"11","author":"La-Beck","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"26","key":"10.1016\/j.addr.2024.115305_b0585","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1016\/j.biomaterials.2011.05.008","article-title":"Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus","volume":"32","author":"Lai","year":"2011","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2011.02.006","article-title":"Pulmonary delivery of therapeutic siRNA","volume":"64","author":"Lam","year":"2012","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0595","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/hsz-2015-0271","article-title":"Neutrophils in cystic fibrosis","volume":"397","author":"Laval","year":"2016","journal-title":"Biological Chemistry"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0600","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0958-1669(94)90085-X","article-title":"Non-viral gene therapy","volume":"5","author":"Ledley","year":"1994","journal-title":"Current Opinion in Biotechnology"},{"issue":"14","key":"10.1016\/j.addr.2024.115305_b0605","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1089\/hum.1996.7.14-1701","article-title":"Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung","volume":"7","author":"Lee","year":"1996","journal-title":"Human Gene Therapy"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0610","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12967-021-03099-4","article-title":"Gene therapy for cystic fibrosis: New tools for precision medicine","volume":"19","author":"Lee","year":"2021","journal-title":"Journal of Translational Medicine"},{"issue":"Pt 1","key":"10.1016\/j.addr.2024.115305_b0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20041923","article-title":"Novel molecular approaches to cystic fibrosis gene therapy","volume":"387","author":"Lee","year":"2005","journal-title":"The Biochemical Journal"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0620","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0005-2736(90)90017-I","article-title":"Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles","volume":"1023","author":"Leventis","year":"1990","journal-title":"Biochimica Et Biophysica Acta"},{"key":"10.1016\/j.addr.2024.115305_b0625","article-title":"Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing","volume":"1\u20136","author":"Li","year":"2023","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0630","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1038\/s41467-022-33157-4","article-title":"Payload distribution and capacity of mRNA lipid nanoparticles","volume":"13","author":"Li","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/j.addr.2024.115305_b0635","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-407697-6.00004-0","article-title":"Cellular and Molecular Biology of Airway Mucins","volume":"303","author":"Lillehoj","year":"2013","journal-title":"International Review of Cell and Molecular Biology"},{"issue":"16","key":"10.1016\/j.addr.2024.115305_b0640","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1089\/10430340260355365","article-title":"Recovery of Airway Cystic Fibrosis Transmembrane Conductance Regulator Function in Mice with Cystic Fibrosis After Single-Dose Lentivirus-Mediated Gene Transfer","volume":"13","author":"Limberis","year":"2002","journal-title":"Human Gene Therapy"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0645","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/nar\/gkac049","article-title":"CRISPR\u2013Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells","volume":"50","author":"Lin-Shiao","year":"2022","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0650","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nbt0297-167","article-title":"Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery","volume":"15","author":"Liu","year":"1997","journal-title":"Nature Biotechnology"},{"issue":"9","key":"10.1016\/j.addr.2024.115305_b0655","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.progpolymsci.2010.04.007","article-title":"Hydrophobic modifications of cationic polymers for gene delivery","volume":"35","author":"Liu","year":"2010","journal-title":"Progress in Polymer Science"},{"issue":"9","key":"10.1016\/j.addr.2024.115305_b0660","first-page":"Article 9","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs. Nature","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Biomedical Engineering"},{"issue":"34","key":"10.1016\/j.addr.2024.115305_b0665","doi-asserted-by":"crossref","first-page":"18760","DOI":"10.1021\/jacs.3c07337","article-title":"Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers","volume":"145","author":"Lu","year":"2023","journal-title":"Journal of the American Chemical Society"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0670","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2007.08.022","article-title":"Lipoplex morphologies and their influences on transfection efficiency in gene delivery","volume":"123","author":"Ma","year":"2007","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"35","key":"10.1016\/j.addr.2024.115305_b0675","doi-asserted-by":"crossref","first-page":"26945","DOI":"10.1074\/jbc.M110.151803","article-title":"Airway Surface Liquid Volume Regulation Determines Different Airway Phenotypes in Liddle Compared with \u03b2ENaC-overexpressing Mice","volume":"285","author":"Mall","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0680","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/genes10030218","article-title":"Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease","volume":"10","author":"Marquez Loza","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.addr.2024.115305_b0685","first-page":"31","article-title":"Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action","volume":"440","author":"Maruggi","year":"2022","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0690","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.colsurfb.2008.09.017","article-title":"Comparison of different commercially available cationic liposome\u2013DNA lipoplexes: Parameters influencing toxicity and transfection efficiency","volume":"68","author":"Masotti","year":"2009","journal-title":"Colloids and Surfaces b: Biointerfaces"},{"issue":"28","key":"10.1016\/j.addr.2024.115305_b0695","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.1502281112","article-title":"Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy","volume":"112","author":"Mastorakos","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b0700","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1074\/jbc.272.2.1117","article-title":"Loss of Binding and Entry of Liposome-DNA Complexes Decreases Transfection Efficiency in Differentiated Airway Epithelial Cells*","volume":"272","author":"Matsui","year":"1997","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0705","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12931-018-0750-y","article-title":"Airway disease phenotypes in animal models of cystic fibrosis","volume":"19","author":"McCarron","year":"2018","journal-title":"Respiratory Research"},{"key":"10.1016\/j.addr.2024.115305_b0710","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1038\/ncomms7952","article-title":"Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium","volume":"6","author":"McNeer","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.addr.2024.115305_b0715","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2021.11.022","article-title":"Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery","volume":"341","author":"Melamed","year":"2022","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"key":"10.1016\/j.addr.2024.115305_b0720","doi-asserted-by":"crossref","unstructured":"Mercier, J., Ruffin, M., Corvol, H., & Guillot, L. (2021). Gene Therapy: A Possible Alternative to CFTR Modulators? Frontiers in Pharmacology, 12. https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.648203.","DOI":"10.3389\/fphar.2021.648203"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0725","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1021\/mp900107v","article-title":"Nonviral siRNA delivery to the lung: Investigation of PEG-PEI polyplexes and their in vivo performance","volume":"6","author":"Merkel","year":"2009","journal-title":"Molecular Pharmaceutics"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0730","article-title":"Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis","volume":"119","author":"Michaels","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0735","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1096\/fj.04-2747rev","article-title":"Nanomedicine: Current status and future prospects","volume":"19","author":"Moghimi","year":"2005","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"45","key":"10.1016\/j.addr.2024.115305_b0740","doi-asserted-by":"crossref","first-page":"18285","DOI":"10.1073\/pnas.1306243110","article-title":"Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing","volume":"110","author":"Montiel-Gonzalez","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7718","key":"10.1016\/j.addr.2024.115305_b0745","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-018-0393-7","article-title":"A revised airway epithelial hierarchy includes CFTR-expressing ionocytes","volume":"560","author":"Montoro","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0750","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2249.2000.01232.x","article-title":"Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes","volume":"120","author":"Moss","year":"2000","journal-title":"Clinical and Experimental Immunology"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0755","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160618","article-title":"Enhancement of lung gene delivery after aerosol: A new strategy using non-viral complexes with antibacterial properties","volume":"37","author":"Mottais","year":"2017","journal-title":"Bioscience Reports"},{"issue":"47","key":"10.1016\/j.addr.2024.115305_b0760","first-page":"eabc5911","article-title":"Engineered mutant \u03b1-ENaC subunit mRNA delivered by lipid nanoparticles reduces amiloride currents in cystic fibrosis\u2013based cell and mice models. Science","volume":"6","author":"Mukherjee","year":"2020","journal-title":"Advances"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0765","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2007.09.013","article-title":"Nano\/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives","volume":"125","author":"Mundargi","year":"2008","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"10","key":"10.1016\/j.addr.2024.115305_b0770","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/v12101106","article-title":"Gene Therapy Applications of Non-Human Lentiviral Vectors","volume":"12","author":"Munis","year":"2020","journal-title":"Viruses"},{"issue":"33\u201334","key":"10.1016\/j.addr.2024.115305_b0775","first-page":"564","article-title":"Cystic Fibrosis","volume":"114","author":"Naehrig","year":"2017","journal-title":"Deutsches \u00c4rzteblatt International"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0780","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mthe.1999.0009","article-title":"Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis","volume":"1","author":"Noone","year":"2000","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0785","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/mt.2012.32","article-title":"Advances in Cell and Gene-based Therapies for Cystic Fibrosis Lung Disease","volume":"20","author":"Oakland","year":"2012","journal-title":"Molecular Therapy"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0790","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcf.2021.12.012","article-title":"Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation","volume":"21","author":"Oren","year":"2022","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b0795","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jcf.2021.06.003","article-title":"Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation","volume":"20","author":"Oren","year":"2021","journal-title":"Journal of Cystic Fibrosis"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0800","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1172\/JCI129635","article-title":"Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation","volume":"130","author":"Ortiz-Mu\u00f1oz","year":"2020","journal-title":"The Journal of Clinical Investigation"},{"issue":"20","key":"10.1016\/j.addr.2024.115305_b0805","doi-asserted-by":"crossref","first-page":"Article 20","DOI":"10.1038\/sj.gt.3302994","article-title":"Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice","volume":"14","author":"Ostrowski","year":"2007","journal-title":"Gene Therapy"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b0810","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/nat.2023.0015","article-title":"Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849 + 10 kb C- > T Cystic Fibrosis Patients","volume":"33","author":"Ozeri-Galai","year":"2023","journal-title":"Nucleic Acid Therapeutics"},{"issue":"34","key":"10.1016\/j.addr.2024.115305_b0815","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1021\/bi060490t","article-title":"CFTR Expression in Human Neutrophils and the Phagolysosomal Chlorination Defect in Cystic Fibrosis","volume":"45","author":"Painter","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2024.115305_b0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122661","article-title":"Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers","volume":"634","author":"Pangeni","year":"2023","journal-title":"International Journal of Pharmaceutics"},{"issue":"21","key":"10.1016\/j.addr.2024.115305_b0825","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.3390\/ijms232112884","article-title":"Self-Amplifying RNA Approach for Protein Replacement Therapy","volume":"23","author":"Papukashvili","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.addr.2024.115305_b0830","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2021.12.030","article-title":"Evolution of drug delivery systems: From 1950 to 2020 and beyond","volume":"342","author":"Park","year":"2022","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"8","key":"10.1016\/j.addr.2024.115305_b0835","first-page":"e1805116","article-title":"Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium. Advanced Materials (Deerfield Beach","volume":"31","author":"Patel","year":"2019","journal-title":"Fla.)"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0840","first-page":"Article 1","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nature","volume":"11","author":"Patel","year":"2020","journal-title":"Communications"},{"issue":"19","key":"10.1016\/j.addr.2024.115305_b0845","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New Developments in Liposomal Drug Delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chemical Reviews"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b0850","doi-asserted-by":"crossref","first-page":"Article 5","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nature Reviews Genetics"},{"key":"10.1016\/j.addr.2024.115305_b0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107169","article-title":"Cystic fibrosis and primary ciliary dyskinesia: Similarities and differences","volume":"209","author":"Pereira","year":"2023","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.addr.2024.115305_b0860","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.678374","article-title":"Ethnic Differences in the Frequency of CFTR Gene Mutations in Populations of the European and North Caucasian Part of the Russian Federation","volume":"12","author":"Petrova","year":"2021","journal-title":"Frontiers in Genetics"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0865","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2016.07.012","article-title":"Enhanced gene delivery to the lung using biodegradable polyunsaturated cationic phosphatidylcholine-detergent conjugates","volume":"511","author":"Pierrat","year":"2016","journal-title":"International Journal of Pharmaceutics"},{"issue":"40","key":"10.1016\/j.addr.2024.115305_b0870","first-page":"eabo0522","article-title":"In vivo correction of cystic fibrosis mediated by PNA nanoparticles. Science","volume":"8","author":"Piotrowski-Daspit","year":"2022","journal-title":"Advances"},{"issue":"7718","key":"10.1016\/j.addr.2024.115305_b0875","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-018-0394-6","article-title":"A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte","volume":"560","author":"Plasschaert","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115305_b0880","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12931-019-1103-1","article-title":"CFTR regulates B cell activation and lymphoid follicle development","volume":"20","author":"Polverino","year":"2019","journal-title":"Respiratory Research"},{"key":"10.1016\/j.addr.2024.115305_b0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110048","article-title":"Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems","volume":"365","author":"Prasher","year":"2022","journal-title":"Chemico-Biological Interactions"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0890","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/6986","article-title":"Spliceosome-mediated RNA trans-splicing as a tool for gene therapy","volume":"17","author":"Puttaraju","year":"1999","journal-title":"Nature Biotechnology"},{"issue":"8","key":"10.1016\/j.addr.2024.115305_b0895","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/j.addr.2024.115305_b0900","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/hum.2006.17.1027","article-title":"Synthetic messenger RNA as a tool for gene therapy","volume":"17","author":"Rabinovich","year":"2006","journal-title":"Human Gene Therapy"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0905","doi-asserted-by":"crossref","first-page":"Article 1","DOI":"10.1038\/nrdp.2015.10","article-title":"Cystic fibrosis","volume":"1","author":"Ratjen","year":"2015","journal-title":"Nature Reviews Disease Primers"},{"issue":"9358","key":"10.1016\/j.addr.2024.115305_b0910","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.addr.2024.115305_b0915","unstructured":"ReCode Therapeutics Announces First Participants Dosed in a Phase 1 Healthy Volunteer Clinical Study of Inhaled mRNA-Based Genetic Medicine, RCT2100, for the Treatment of Cystic Fibrosis. (2024, February 21). https:\/\/recodetx.com\/recode-therapeutics-announces-first-participants-dosed-in-a-phase-1-healthy-volunteer-clinical-study-of-inhaled-mrna-based-genetic-medicine-rct2100-for-the-treatment-of-cystic-fibrosis\/."},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0920","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009555","article-title":"Status of Fluid and Electrolyte Absorption in Cystic Fibrosis","volume":"3","author":"Reddy","year":"2013","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"8","key":"10.1016\/j.addr.2024.115305_b0925","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.ymthe.2018.05.014","article-title":"Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis","volume":"26","author":"Robinson","year":"2018","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"issue":"31","key":"10.1016\/j.addr.2024.115305_b0930","doi-asserted-by":"crossref","first-page":"12771","DOI":"10.1073\/pnas.0906850106","article-title":"Basal cells as stem cells of the mouse trachea and human airway epithelium","volume":"106","author":"Rock","year":"2009","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0935","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"Journal of Cystic Fibrosis"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b0940","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/1521-2254(200007\/08)2:4<269::AID-JGM112>3.0.CO;2-F","article-title":"In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers","volume":"2","author":"Rudolph","year":"2000","journal-title":"The Journal of Gene Medicine"},{"key":"10.1016\/j.addr.2024.115305_b0945","article-title":"Airway Basal Cells, Protectors of Epithelial Walls in Health and Respiratory Diseases. Frontiers","volume":"2","author":"Ruysseveldt","year":"2021","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.addr.2024.115305_b0950","doi-asserted-by":"crossref","first-page":"Article 7","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nature Biotechnology"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0955","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.gt.3301663","article-title":"Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus","volume":"9","author":"Sanders","year":"2002","journal-title":"Gene Therapy"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b0960","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1164\/ajrccm.162.5.9909009","article-title":"Cystic fibrosis sputum: A barrier to the transport of nanospheres","volume":"162","author":"Sanders","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b0965","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1164\/ajrccm.164.3.2011041","article-title":"Structural alterations of gene complexes by cystic fibrosis sputum","volume":"164","author":"Sanders","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b0970","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jcf.2021.05.014","article-title":"Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation","volume":"21","author":"Santos","year":"2022","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0975","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/hum.1997.8.6-689","article-title":"Basis of Pulmonary Toxicity Associated with Cationic Lipid-Mediated Gene Transfer to the Mammalian Lung","volume":"8","author":"Scheule","year":"1997","journal-title":"Human Gene Therapy"},{"issue":"9","key":"10.1016\/j.addr.2024.115305_b0980","doi-asserted-by":"crossref","first-page":"Article 9","DOI":"10.1038\/s41434-019-0092-5","article-title":"Beyond cystic fibrosis transmembrane conductance regulator therapy: A perspective on gene therapy and small molecule treatment for cystic fibrosis","volume":"26","author":"Schneider-Futschik","year":"2019","journal-title":"Gene Therapy"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b0985","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional Repair of CFTR by CRISPR\/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.addr.2024.115305_b0990","doi-asserted-by":"crossref","first-page":"10612","DOI":"10.1021\/nn403069n","article-title":"Effect of Polyplex Morphology on Cellular Uptake, Intracellular Trafficking, and Transgene Expression","volume":"7","author":"Shi","year":"2013","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.addr.2024.115305_b0995","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242094","article-title":"P.F508del editing in cells from cystic fibrosis patients","volume":"15","author":"Smirnikhina","year":"2020","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b1000","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81099-5","article-title":"Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid","volume":"85","author":"Smith","year":"1996","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b1005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/gb4150","article-title":"Exon identity crisis: Disease-causing mutations that disrupt the splicing code","volume":"15","author":"Sterne-Weiler","year":"2014","journal-title":"Genome Biology"},{"issue":"29","key":"10.1016\/j.addr.2024.115305_b1010","doi-asserted-by":"crossref","first-page":"29ra31","DOI":"10.1126\/scitranslmed.3000928","article-title":"Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth","volume":"2","author":"Stoltz","year":"2010","journal-title":"Science Translational Medicine"},{"issue":"23","key":"10.1016\/j.addr.2024.115305_b1015","doi-asserted-by":"crossref","first-page":"11277","DOI":"10.1073\/pnas.89.23.11277","article-title":"Aerosol gene delivery in vivo","volume":"89","author":"Stribling","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.addr.2024.115305_b1020","doi-asserted-by":"crossref","first-page":"1015926","DOI":"10.3389\/fphar.2022.1015926","article-title":"Gene therapy for cystic fibrosis: Challenges and prospects","volume":"13","author":"Sui","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"30","key":"10.1016\/j.addr.2024.115305_b1025","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.biomaterials.2008.12.076","article-title":"The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles","volume":"13","author":"Suk","year":"2009","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.addr.2024.115305_b1030","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1021\/mp3004176","article-title":"Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties","volume":"9","author":"Sunshine","year":"2012","journal-title":"Molecular Pharmaceutics"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b1035","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/oxfordjournals.bmb.a072574","article-title":"Milestones in cystic fibrosis","volume":"48","author":"Super","year":"1992","journal-title":"British Medical Bulletin"},{"issue":"7","key":"10.1016\/j.addr.2024.115305_b1040","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.ymthe.2020.04.021","article-title":"Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR Correction","volume":"28","author":"Suzuki","year":"2020","journal-title":"Molecular Therapy"},{"issue":"10","key":"10.1016\/j.addr.2024.115305_b1045","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/infdis\/jix474","article-title":"A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense","volume":"216","author":"Svedin","year":"2017","journal-title":"The Journal of Infectious Diseases"},{"issue":"5","key":"10.1016\/j.addr.2024.115305_b1050","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1242\/dev.143784","article-title":"Plasticity in the lung: Making and breaking cell identity","volume":"144","author":"Tata","year":"2017","journal-title":"Development"},{"issue":"7","key":"10.1016\/j.addr.2024.115305_b1055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nbt0797-647","article-title":"Improved DNA: Liposome complexes for increased systemic delivery and gene expression","volume":"15","author":"Templeton","year":"1997","journal-title":"Nature Biotechnology"},{"issue":"6","key":"10.1016\/j.addr.2024.115305_b1060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjugate Chemistry"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b1065","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1021\/acs.langmuir.0c03039","article-title":"Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach","volume":"37","author":"Terada","year":"2021","journal-title":"Langmuir: the ACS Journal of Surfaces and Colloids"},{"issue":"16","key":"10.1016\/j.addr.2024.115305_b1070","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1073\/pnas.0502067102","article-title":"Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung","volume":"102","author":"Thomas","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b1075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.physiol.70.113006.100702","article-title":"Structure and Function of the Polymeric Mucins in Airways Mucus","volume":"70","author":"Thornton","year":"2008","journal-title":"Annual Review of Physiology"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b1080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-2600(19)30333-9","article-title":"Progress in understanding the molecular pathology and microbiology of cystic fibrosis","volume":"8","author":"T\u00fcmmler","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b1085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1183\/18106838.0203.252","article-title":"The mesh nebuliser: A recent technical innovation for aerosol delivery","volume":"2","author":"Vecellio","year":"2006","journal-title":"Breathe"},{"issue":"12","key":"10.1016\/j.addr.2024.115305_b1090","doi-asserted-by":"crossref","first-page":"Article 12","DOI":"10.3390\/cells12121555","article-title":"Genome Editing for Cystic Fibrosis","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b1095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1165\/ajrcmb.22.2.3938","article-title":"Increasing epithelial junction permeability enhances gene transfer to airway epithelia In vivo","volume":"22","author":"Wang","year":"2000","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b1100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1165\/ajrcmb.24.2.3918","article-title":"New models of the tracheal airway define the glandular contribution to airway surface fluid and electrolyte composition","volume":"24","author":"Wang","year":"2001","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"50","key":"10.1016\/j.addr.2024.115305_b1105","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles that \u201cSlip\u201d through the Human Mucus Barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angewandte Chemie (international Ed. in English)"},{"issue":"41","key":"10.1016\/j.addr.2024.115305_b1110","doi-asserted-by":"crossref","first-page":"25710","DOI":"10.1016\/S0021-9258(18)47306-1","article-title":"Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins","volume":"269","author":"Ward","year":"1994","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.addr.2024.115305_b1115","doi-asserted-by":"crossref","unstructured":"Wei, T., Sun, Y., Cheng, Q., Chatterjee, S., Traylor, Z., Johnson, L. T., Coquelin, M. L., Wang, J., Torres, M. J., Lian, X., Wang, X., Xiao, Y., Hodges, C. A., & Siegwart, D. J. (2023). Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models. Nature Communications, 14(1), Article 1. doi: 10.1038\/s41467-023-42948-2.","DOI":"10.1038\/s41467-023-42948-2"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b1120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1021\/bc800428y","article-title":"A Biodegradable Low Molecular Weight Polyethylenimine Derivative as Low Toxicity and Efficient Gene Vector","volume":"20","author":"Wen","year":"2009","journal-title":"Bioconjugate Chemistry"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b1125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/acsnano.8b05151","article-title":"Super-resolution Imaging of Proton Sponge-Triggered Rupture of Endosomes and Cytosolic Release of Small Interfering RNA","volume":"13","author":"Wojnilowicz","year":"2019","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.addr.2024.115305_b1130","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1089\/hum.1997.8.14-1675","article-title":"Role of Alveolar Macrophages in Rapid Elimination of Adenovirus Vectors Administered to the Epithelial Surface of the Respiratory Tract","volume":"8","author":"Worgall","year":"1997","journal-title":"Human Gene Therapy"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b1135","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1021\/acsami.0c21259","article-title":"Poly(lactide-co-glycolide) Nanoparticles Mediate Sustained Gene Silencing and Improved Biocompatibility of siRNA Delivery Systems in Mouse Lungs after Pulmonary Administration","volume":"13","author":"Wu","year":"2021","journal-title":"ACS Applied Materials & Interfaces"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b1140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12931-022-02042-5","article-title":"Roles of airway basal stem cells in lung homeostasis and regenerative medicine","volume":"23","author":"Wu","year":"2022","journal-title":"Respiratory Research"},{"issue":"9","key":"10.1016\/j.addr.2024.115305_b1145","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"issue":"28","key":"10.1016\/j.addr.2024.115305_b1150","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1039\/D3TB00649B","article-title":"Rational design and combinatorial chemistry of ionizable lipids for RNA delivery","volume":"11","author":"Xu","year":"2023","journal-title":"Journal of Materials Chemistry B"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b1155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1165\/rcmb.2012-0021OC","article-title":"Low Sphingosine-1\u2013Phosphate Impairs Lung Dendritic Cells in Cystic Fibrosis","volume":"48","author":"Xu","year":"2013","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"1","key":"10.1016\/j.addr.2024.115305_b1160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1465-9921-10-26","article-title":"Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells","volume":"10","author":"Xu","year":"2009","journal-title":"Respiratory Research"},{"issue":"39","key":"10.1016\/j.addr.2024.115305_b1165","first-page":"E5702","article-title":"Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells","volume":"113","author":"Yan","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/j.addr.2024.115305_b1170","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1021\/acs.biomac.7b01356","article-title":"Systemic mRNA Delivery to the Lungs by Functional Polyester-based Carriers","volume":"18","author":"Yan","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2024.115305_b1175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biomaterials.2016.12.001","article-title":"Aerosol delivery of stabilized polyester-siRNA nanoparticles to silence gene expression in orthotopic lung tumors","volume":"118","author":"Yan","year":"2017","journal-title":"Biomaterials"},{"issue":"R1","key":"10.1016\/j.addr.2024.115305_b1180","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1093\/hmg\/ddz139","article-title":"Advances in gene therapy for cystic fibrosis lung disease","volume":"28","author":"Yan","year":"2019","journal-title":"Human Molecular Genetics"},{"issue":"12","key":"10.1016\/j.addr.2024.115305_b1185","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1093\/nar\/20.12.3233","article-title":"Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer","volume":"20","author":"Yoshimura","year":"1992","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.addr.2024.115305_b1190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000155","article-title":"CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium","author":"Zhang","year":"2009","journal-title":"PLoS Biology"},{"issue":"4","key":"10.1016\/j.addr.2024.115305_b1195","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1039\/D0BM01609H","article-title":"Helper Lipid Structure Influences Protein Adsorption and Delivery of Lipid Nanoparticles to Spleen and Liver","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomaterials Science"},{"issue":"3","key":"10.1016\/j.addr.2024.115305_b1200","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jcf.2018.07.006","article-title":"Antisense oligonucleotide targeting of mRNAs encoding ENaC subunits \u03b1, \u03b2, and \u03b3 improves cystic fibrosis-like disease in mice","volume":"18","author":"Zhao","year":"2019","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1016\/j.addr.2024.115305_b1205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2022.09.021","article-title":"Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery","volume":"351","author":"Zimmermann","year":"2022","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"2","key":"10.1016\/j.addr.2024.115305_b1210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1521-2254(200003\/04)2:2<128::AID-JGM95>3.0.CO;2-W","article-title":"Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse","volume":"2","author":"Zou","year":"2000","journal-title":"The Journal of Gene Medicine"},{"issue":"7","key":"10.1016\/j.addr.2024.115305_b1215","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/sj.mt.6300132","article-title":"Rapid Optimization of Gene Delivery by Parallel End-modification of Poly(\u03b2-amino ester)s","volume":"15","author":"Zugates","year":"2007","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T16:15:12Z","timestamp":1716135312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X24001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":243,"alternative-id":["S0169409X24001273"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2024.115305","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2024.115305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115305"}}